Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
The antibody represents the core of LHNVD-303, the cornerstone therapy for infection control and inflammation in Longhorn's Anti-PAMP platform and inflammaging/longevity portfolio Longhorn Vaccines ...
The Fall Intersections Undergraduate Research Poster Session will be held Friday, Dec. 6, from 11:30 a.m. to 2 p.m. in the Veale Convocation, Recreation, and Athletic Center. Intersections is a ...
Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the ...